Clinical Trials
101 trialsPhase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer
National Health Research Institutes, Taiwan
Pancreas
National Health Research Institutes, Taiwan
MK-3475-811
Merck Sharp & Dohme LLC
PREACT
Shanghai Cancer Hospital, China
Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
The First Affiliated Hospital with Nanjing Medical University
Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer
Fujian Medical University
Neoadjuvant Immunotherapy for Resectable Gastric Cancer
Qilu Hospital of Shandong University
Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer
Taiho Oncology, Inc.
A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1
Taiho Oncology, Inc.
A Trial of TAS-114 in Combination With S-1
Taiho Oncology, Inc.
Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer
Taiho Oncology, Inc.
A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors
Taiho Oncology, Inc.
Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer
Taiho Oncology, Inc.
Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer
Taiho Oncology, Inc.
Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung Cancer
Taiho Oncology, Inc.
A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer
The First Hospital of Jilin University
CHANGE
Shanghai University of Traditional Chinese Medicine
PRODIGY
Sanofi
A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer
Qingdao Central Hospital
Maintenance Therapy for Small-cell Lung Cancer
Qingdao Central Hospital
Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma
Sun Yat-sen University
MATCH
ChineseAMS
SOLAR
National Health Research Institutes, Taiwan
S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer
Zhejiang University
Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract
Chinese PLA General Hospital
S-1 adjuvant
AIO-Studien-gGmbH
MATEO
AIO-Studien-gGmbH
S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Fudan University
Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer
ChineseAMS
Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer
Beijing Friendship Hospital
Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer
Japan Adjuvant Study Group of Pancreatic Cancer
Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
Seoul National University Hospital
Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer
Changhai Hospital
S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer
Zhejiang Cancer Hospital
Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.
Sun Yat-sen University
Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01
ChineseAMS
Perioperative Chemotherapy for Potentially Resectable Gastric Cancer
Hebei Medical University
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS
Asan Medical Center
EASE
Changzhou Cancer Hospital of Soochow University
Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma
First People's Hospital of Hangzhou
SOX
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma
ChineseAMS
SIRINOX
Institut du Cancer de Montpellier - Val d'Aurelle
Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer
Taiho Pharmaceutical Co., Ltd.
GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer
Kansai Hepatobiliary Oncology Group
Study of S-1 in Combination With Radiotherapy in Esophageal Cancer
Fudan University
S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients
Sun Yat-sen University
Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer
Capital Medical University